Merck & Co Inc (MRK)

Add to Watchlists
Create an Alert
Quickflows
77.64 +0.17  +0.22% NYSE Apr 19, 09:09 USD
View Full Chart
Price Chart
View All Key Stats

Key Stats

View All MRK News

News

View All Events

Events

Date Type Description
04/28/2020 08:00 EDT Earnings Calls Q1 2020 Earnings Call
04/28/2020 00:00 Earnings Results Q1 2020 Earnings Results
05/26/2020 09:00 EDT Agm 2019 Annual General Meeting
06/12/2020 None Dividends 0.61 Normal, declared May 26, 2020 and paid July 07, 2020
07/31/2020 08:00 EDT Earnings Calls Q2 2020 Earnings Call
07/31/2020 00:00 Earnings Results Q2 2020 Earnings Results
09/14/2020 None Dividends 0.61 Normal, declared July 28, 2020 and paid October 07, 2020
10/27/2020 08:00 EDT Earnings Calls Q3 2020 Earnings Call
10/27/2020 00:00 Earnings Results Q3 2020 Earnings Results
12/14/2020 None Dividends 0.65 Normal, declared November 11, 2020 and paid January 08, 2021
View All Performance Charts

Total Returns Comparison

Fundamentals

Income Statement View Statement

Revenue (TTM) 48.00B
Total Expenses (TTM) 39.51B
Net Income (TTM) 7.068B

Balance Sheet View Statement

Total Assets (Quarterly) 91.59B
Total Liabilities (Quarterly) 66.18B
Shareholders Equity (Quarterly) 25.32B

Cash Flow Statement View Statement

Cash from Operations (TTM) 10.25B
Cash from Investing (TTM) -9.443B
Cash from Financing (TTM) -2.832B

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to 40% of the firm's sales are generated in the United States.
  • URL: https://www.merck.com
  • Investor Relations URL: http://investors.merck.com/investors/default.aspx
  • HQ State/Province: New Jersey
  • Sector: Healthcare
  • Industry: Drug Manufacturers - General
  • Equity Style: Large Cap/Value
  • Next Earnings Release: Apr. 29, 2021
  • Last Earnings Release: Feb. 04, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Mar. 12, 2021

Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 77.64
Price Target Upgrade
Price Target Upside (Daily) Upgrade

Top Fund Holders

Symbol Name Weighting
XLV Health Care Select Sector SPDR® ETF 4.31%
SCHD Schwab US Dividend Equity ETF™ 3.86%
VHT Vanguard Health Care ETF 3.46%
VDIGX Vanguard Dividend Growth Inv 2.41%
VEIPX Vanguard Equity-Income Inv 1.77%
FISRX Franklin Income R 1.70%
VYM Vanguard High Dividend Yield ETF 1.60%
VHYAX Vanguard High Dividend Yield Index Adm 1.53%
VIVAX Vanguard Value Index Inv 1.23%
VTV Vanguard Value ETF 1.23%
CMLFX American Funds American Mutual 529F 1.11%
IWF iShares Russell 1000 Growth ETF 0.86%

Comparables

Edit
REGN Regeneron Pharmaceuticals Inc
MRNA Moderna Inc
GILD Gilead Sciences Inc
JNJ Johnson & Johnson
LLY Eli Lilly and Co

Other Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.